<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03738332</url>
  </required_header>
  <id_info>
    <org_study_id>UPCC12318</org_study_id>
    <nct_id>NCT03738332</nct_id>
  </id_info>
  <brief_title>Low-Level Laser in Treatment of Head and Neck Lymphedema: A Pilot Study</brief_title>
  <official_title>Low-Level Laser in Treatment of Head and Neck Lymphedema: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this pilot clinical trial is to evaluate the feasibility of the use of&#xD;
      low-level laser for head and neck cancer survivors with lymphedema.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary aim:&#xD;
&#xD;
      To determine the feasibility of the use of LLLT for HNC survivors with lymphedema,&#xD;
      specifically to 1) obtain recruitment estimates and determine barriers to recruitment; 2)&#xD;
      identify barriers to implementation; 3) assess safety; and 4) evaluate patient satisfaction.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 25, 2019</start_date>
  <completion_date type="Actual">December 31, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Pre-and post design</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recruitment rate</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Recruitment rate and barriers to recruitment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Completion rate</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Barriers to completion of the study intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety - adverse events rate</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Adverse events</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient satisfaction rate</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Patient satisfaction rate</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Head and Neck Cancer</condition>
  <condition>Lymphedema</condition>
  <condition>Fibrosis</condition>
  <arm_group>
    <arm_group_label>Low-level laser therapy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Single arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Low-Level Laser</intervention_name>
    <description>Low-level laser therapy</description>
    <arm_group_label>Low-level laser therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  &gt;18 years of age&#xD;
&#xD;
          -  Completion of either postoperative radiation or chemoradiation therapy&#xD;
&#xD;
          -  No evidence of cancer&#xD;
&#xD;
          -  Having head and neck external lymphedema&#xD;
&#xD;
          -  Either completion of lymphedema therapy or not in active lymphedema therapy&#xD;
&#xD;
          -  Ability to speak and read English&#xD;
&#xD;
          -  Able to provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients will be excluded if they have any of the following medical conditions that would&#xD;
        prohibit the safe implementation of LLLT: pregnancy; photosensitivity; chronic inflammatory&#xD;
        diseases; venous thrombosis; history of severe trauma; medication that affects body fluid&#xD;
        and electrolyte balance; use of high doses of non-steroidal anti-inflammatory drugs; or&#xD;
        pre-existing skin rash, ulceration, open wound in the treatment area; and allergic and&#xD;
        other systemic skin diseases.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Pennsylvania Abramson Cancer Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>November 8, 2018</study_first_submitted>
  <study_first_submitted_qc>November 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2018</study_first_posted>
  <last_update_submitted>February 7, 2021</last_update_submitted>
  <last_update_submitted_qc>February 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pennsylvania</investigator_affiliation>
    <investigator_full_name>Jie Deng</investigator_full_name>
    <investigator_title>Associate Professor, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphedema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>November 14, 2021</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

